Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node RadiationMonika L. Metzger, Matthew J. Krasin, Jamie E. Flerlage et al.|Journal of Clinical Oncology|2021Cited by 59
Predictors of Survival, Neurologic Death, Local Failure, and Distant Failure After Gamma Knife Radiosurgery for Melanoma Brain MetastasesMatthew T. Neal, Thomas L. Ellis, Michael D. Chan et al.|World Neurosurgery|2013Cited by 55
CD19 CAR T-cell therapy demonstrates activity against extramedullary disease in pediatric patients with B-ALLRebecca Epperly, Aimee C. Talleur, Barry L. Shulkin et al.|Blood Advances|2023Cited by 9
Dose-dense chemotherapy enables elimination of RT for the majority of low-risk pediatric Hodgkin lymphomas: PHC study HOD08Jamie E. Flerlage, M Link, Angela M. Feraco et al.|Blood|2026Cited by 2
A Competing Risk Analysis of Neurologic Versus Nonneurologic Death in Patients Undergoing Radiosurgical Salvage Following Whole Brain Radiation Therapy Failure (WBRT): Who Actually Dies of Their Brain Metastases?John T. Lucas, Michael D. Chan, H.G. Colmer et al.|International Journal of Radiation Oncology*Biology*Physics|2013Cited by 2